Skip to content

InformationSeekingMesolimbicEngagementStudy1

The Influence of Mesolimbic-hippocampal Interactions on Episodic Memory During Active Information Seeking

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06257446
Enrollment
76
Registered
2024-02-14
Start date
2023-10-25
Completion date
2024-02-09
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motivation

Brief summary

Study 1 will use a novel Game Show task, in which the investigators manipulate participant's agency to control their learning environment to specify unguided exploration.

Detailed description

Study 1 will use a novel Game Show task, in which the investigators manipulate participant's agency to control their learning environment to specify unguided exploration. In the encoding session, participants play the producer for a game show. On each trial, participants are shown a trial-unique contestant (2s), and then they select one of 3 presented doors to reveal a hidden object (4 seconds). The selected door is then highlighted (2-4s), which is then removed to show a trial-unique object image, which is framed as a prize (2s). On exploration trials, participants actively select which door to open. On control trials, the participant is forced to select a highlighted door, fostering passive rather than active information seeking. Unbeknownst to participants, there is no relationship between selected doors and revealed objects, as objects are pre-selected for each trial. Thus, timing, motor demands, and visual information are fixed across conditions. Participants will complete 3 runs of both the exploration and control condition, with each run containing 20 trials. Temporal jitters are placed between cues and outcomes and between trials, as determined by design optimization software77. Run will be pseudo-randomized across participants so no more than 2 runs of the same condition will appear in a row. Following encoding, participants will complete immediate and delayed item-associative memory test. On each trial of the memory test, participants will view the characters presented during exploration and control trials as well as new foil characters. If a participant indicates that they have previously seen a character before, the participants will be shown three object images encountered during encoding, and decide which item served as a prize for that specific character. In this way, the investigators can resolve memory for contestants (i.e., cues), and associative binding across contestants and prizes (i.e., cue-outcome). Participants memory will be tested for half the stimuli immediately and at a 24-hour delay.

Interventions

Participants will be given cued instructions as to whether they are in a high or low motivation condition

Sponsors

Temple University
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* 20/40 far acuity (either corrected or uncorrected) * In good medical health

Exclusion criteria

* History of head injury * History of illness with Central Nervous Systems implications * On Medications that Affect blood flow response and alertness * Consumption of smoking and/or coffee 30 minutes prior to laboratory testing * Placement of a device contraindicated for magnetic resonance imaging including cardia pacemaker, aneurysm clip, cochlear implants, pregnancy, intra-uterine device, shrapnel, metal fragments in the eyes, neurostimulators * Weight \> 250lbs * Claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
Mesolimbic-hippocampal InteractionsDuring ProcedureFunctional Magnetic Resonance Imaging Activation characterizing mesolimbic-hippocampal interactions as queried using representational simliarity analysis across these two regions of interest. In this analysis, we explore the pattern similarity within the same set of regions (mesolimbic and hippocampal regions) across different trial types. In this way the standard unit for these values reflect a correlation that is summarized by a standardized beta-value extracted from a nested mixed effects model.
Episodic Memory24-hours, we administered our memory test 24 hours after the first session but this is the first time we are administering this test.Item and Associative memory for memoranda shown during the task. This measure reflects the percent of memory test retrieval trials in which participants were able to successfull remember an item and its associated features compared across a high and low reward condition.

Countries

United States

Participant flow

Recruitment details

Recruitment Status: Completed Study Start Date: October 25, 2023 Primary Completion Date: February 09, 2024 Study Completion Date: February 09, 2024 Enrollment (Actual): 76 participants Study Locations: Temple University, Philadelphia, PA, United States

Pre-assignment details

Of the 76 participants that were recruiteted, 0 were excluded prior to assignment.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
76 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
12 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
51 Participants
Region of Enrollment
United States
76 participants
Sex: Female, Male
Female
46 Participants
Sex: Female, Male
Male
30 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 74
other
Total, other adverse events
0 / 74
serious
Total, serious adverse events
0 / 74

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026